Clinical Trial Update: Severe Group A Streptococcus Infections in Paris, France, 2018-2023

View source ↗

Summary

A completed clinical trial in Paris (2018-2023) evaluating treatments for severe invasive Group A streptococcal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Group Streptococcal Infection

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Invasive Group A Beta-Haemolytic Streptococcal Disease | Status: COMPLETED